In 1993, a system of effectively extending the patent term of protection for particular pharmaceutical products was introduced by the use of supplementary protection certificates (“SPCs”), further to Council Regulation (EEC) No 1768/92 (now Regulation 469/2009/EC) (“SPC Regulation”).
This Guidance Note explains the purpose of SPCs, the conditions for obtaining them and how the length of protection is determined . . .
This content is restricted to subscribers. To view this content please register an account.
If you are already a subscriber, please login below.